ICT Module III

Back to Integrative Cancer Therapy Fellowship

Register Now

ICT Online Module III


Integrative Cancer Therapy Fellowship Module III: Immunology of Cancer

Upon completion of the module, the participant will:

  • Review current concepts in immunology
  • Know the immunological tests that are currently available
  • Review the medical literature on immunosuppression and cancer
  • Look at the multifactorial basis of immunodeficiency in cancer patients
  • Understand effector cell numbers and function
  • Know immunoregulatory cells and immunomodulatory factors
  • Look at immunosuppression and tumor cell burden
  • Understand the function of T-lymphocytes, T-helper cells, T-suppressor cells, T-cytotoxic cells, B lymphocytes, monocytes, macrophages, natural killer cells, and lymphokine-activated killer cells
  • Evaluate sold tumors in the light of immunological function
  • Understand hematopoietic malignancies in the light of immunology
  • Evaluate radiation-induced immunosuppression
  • Comprehend chemotherapy-induced immunosuppression
  • Look at the immune status of patients in clinical remission
  • Lean treatments of caner-associated immunodeficiency
  • Know biological response modifiers with immunorestorative properties
  • Understand the chemical properties of thymic hormones
  • Learn treatment of radiotherapy-induced immunosuppression
  • Learn therapies for chemotherapy-induced immunosuppression
  • Learn about cancer vaccines
  • Understand the cytokine sources and their effects related to the growth and treatment of cancer
  • Have a working knowledge of all of the interleukins
  • Understand tumor necrosis factor alpha and its effects on inflammation, immune regulation, apoptosis, and endothelial damage
  • Understand interferon therapy for specific cancers
  • Understand the mode of action of interferons in cancer treatment
  • Learn about monoclonal antibody therapy
  • Study immunotoxins
  • Learn new testing methods for immunological markers
  • Train in granulocyte colony-stimulating factor therapies
  • Understand the clinical implications of granulocyte-macrophage colony-stimulating factor therapies and immunomodulation
  • Review heat shock proteins as regulators of the immune response
  • Understand the role of gene rearrangement in the tumor response
  • Look at how tumors avoid the immune response


Low Dose Metronomic Chemotherapy Mark Rosenberg, MD 1 hr
Organs of the Immune System Dwight McKee, MD 1 hr
Introduction of Immunology: The Immune System Dwight McKee, MD 1 hr
Introduction to Tumor Immunology Dwight McKee, MD 1 hr
Advanced Tumor Immunotherapy Dwight KcKee, MD 1 hr
ImmunoCompetence/ ImmuneDeficiency and Clinical Course Donald Braun, PhD 1 hr
Immune Response to Cancer in Different Anatomic Sites Donald Braun, PhD 1 hr
Cytokine-Based Immune Therapies Donald Braun, PhD 1 hr
Adoptive Cellular Immunotherapy of Cancer Donald Braun, PhD 1 hr
Monoclonal Ab Therapy to Cancer Donald Braun, PhD 1 hr
GcMAF Dwight KcKee, MD 1 hr
Stress, Immune System and Cancer Dwight McKee, MD 1 hr
Inflammation, Gut Integrity, Diet and Immune Functions Dwight McKee, MD 1 hr
Mechanisms of Immune Suppression By Tumor Cells Dwight McKee, MD 1 hr
Cancer Vaccination Strategies: Clinical Results Donald Braun, PhD 2 hr
Obesity, Insulin and Cancer: The Role of the Insulin-IGF Pathway on the Origins and the Outcome of Cancer Barry Boyd, MD 2 hr
Mechanisms for Collaboration Between Conventional Therapy and AntiTumor Immunity Donald Braun, PhD 1 hr
Effects of Naturopathic/Nutritional Supplements on Immune Response to Cancer Donald Braun, PhD 1 hr
Integrative Approach to Prostate Cancer Pyuish Bhatnagar, MD 1 hr
Integrative Approach to Lung Cancer Pyuish Bhatnagar, MD 1 hr
Epigenetic Regulation of DNA Repair Pathways and Their Modulation to Reverse Chemotherapy Resistance in Melanoma Hussein Tawbi, MD 2 hr